| Issue Date | Title | Author(s) |
| 28-Jan-2024 | AKT2<SUP>S128</SUP>/CCTα<SUP>S315/319/323</SUP>-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs) | Chen, Jie; Zhang, Lingyuan; Zhu, Yuheng; Zhao, Di; Zhang, Jing; Zhu, Yanmeng; Pang, Jingyuan; Xiao, Yuanfan; Wu, Qingnan; Wang, Yan; Zhan, Qimin |
| 2019 | APC/C-CDH1-Regulated IDH3 beta Coordinates with the Cell Cycle to Promote Cell Proliferation | Wu, Qingnan; Zhang, Weimin; Xue, Liyan; Wang, Yan; Fu, Ming; Ma, Liying; Song, Yongmei; Zhan, Qi-Min |
| 2-Aug-2020 | Automatic segmentation of pelvic organs-at-risk using a fusion network model based on limited training samples | Ju, Zhongjian; Wu, Qingnan; Yang, Wei; Gu, Shanshan; Guo, Wen; Wang, Jinyuan; Ge, Ruigang; Quan, Hong; Liu, Jie; Qu, Baolin |
| 16-Aug-2023 | CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties | Lv, Mengzhu; Gong, Ying; Liu, Xuesong; Wang, Yan; Wu, Qingnan; Chen, Jie; Min, Qingjie; Zhao, Dongyu; Li, Xianfeng; Chen, Dongshao; Yang, Di; Yeerken, Danna; Liu, Rui; Li, Jinting; Zhang, Weimin; Zhan, Qimin |
| 2018 | The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment | Zhang, Weimin; Hong, Ruoxi; Li, Lin; Wang, Yan; Du, Peina; Ou, Yunwei; Zhao, Zitong; Liu, Xuefeng; Xiao, Wenchang; Dong, Dezuo; Wu, Qingnan; Chen, Jie; Song, Yongmei; Zhan, Qimin |
| Dec-2023 | Co-targeting FAK and Gli1 inhibits the tumor-associated macrophages-released CCL22-mediated esophageal squamous cell carcinoma malignancy | Chen, Jie; Zhu, Yanmeng; Zhao, Di; Zhang, Lingyuan; Zhang, Jing; Xiao, Yuanfan; Wu, Qingnan; Wang, Yan; Zhan, Qimin |
| Aug-2022 | FAM135B sustains the reservoir of Tip60-ATM assembly to promote DNA damage response | Zhang, Kai; Wu, Qingnan; Liu, Wenzhong; Wang, Yan; Zhao, Lianmei; Chen, Jie; Liu, Haoyu; Liu, Siqi; Li, Jinting; Zhang, Weimin; Zhan, Qimin |
| 8-Sep-2021 | Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma | Min, Qingjie; Wang, Yan; Wu, Qingnan; Li, Xianfeng; Teng, Huajing; Fan, Jiawen; Cao, Yiren; Fan, Pingsheng; Zhan, Qimin |
| 2022 | The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma | Liu, Xuesong; Hong, Ruoxi; Du, Peina; Yang, Di; He, Meibo; Wu, Qingnan; Li, Lin; Wang, Yan; Chen, Jie; Min, Qingjie; Li, Jinting; Zhang, Weimin; Zhan, Qimin |
| Feb-2023 | Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma | Zhang, Jing; Zhao, Di; Zhang, Lingyuan; Xiao, Yuanfan; Wu, Qingnan; Wang, Yan; Chen, Jie; Zhan, Qimin |
| Aug-2022 | Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC) | Chen, Jie; Zhao, Di; Zhang, Lingyuan; Zhang, Jing; Xiao, Yuanfan; Wu, Qingnan; Wang, Yan; Zhan, Qimin |
| Mar-2024 | Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis | Chen, Jie; Zhao, Di; Zhang, Lingyuan; Zhang, Jing; Xiao, Yuanfan; Wu, Qingnan; Wang, Yan; Zhan, Qimin |
